Clearpoint Neuro Inc (CLPT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Clearpoint Neuro Inc (CLPT) has a cash flow conversion efficiency ratio of -0.651x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-7.01 Million) by net assets ($10.78 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see CLPT market cap overview for the company's overall valuation and market capitalisation.
Clearpoint Neuro Inc - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Clearpoint Neuro Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Clearpoint Neuro Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Clearpoint Neuro Inc ranked by their cash flow conversion efficiency. Explore cash flow quality index of Clearpoint Neuro Inc to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NOVA Technology Corporation Limited
SHE:300921
|
N/A |
|
Kura Sushi USA Inc
NASDAQ:KRUS
|
0.045x |
|
Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd
SHE:300313
|
-0.906x |
|
ITAB Shop Concept AB ser. B
ST:ITAB
|
-0.002x |
|
Cheng Du Sheng Nuo Biotec Co. Ltd. A
SHG:688117
|
-0.021x |
|
Zhejiang Heda Technology Co Ltd
SHG:688296
|
-0.012x |
|
ZheJiang Haers Vacuum Containers Co Ltd
SHE:002615
|
0.076x |
|
Vital Farms Inc
NASDAQ:VITL
|
-0.096x |
Annual Cash Flow Conversion Efficiency for Clearpoint Neuro Inc (2011–2025)
The table below shows the annual cash flow conversion efficiency of Clearpoint Neuro Inc from 2011 to 2025. View Clearpoint Neuro Inc (CLPT) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $28.02 Million | $-23.93 Million | -0.854x | -142.22% |
| 2024-12-31 | $25.39 Million | $-8.95 Million | -0.353x | +45.60% |
| 2023-12-31 | $21.17 Million | $-13.72 Million | -0.648x | -47.85% |
| 2022-12-31 | $36.89 Million | $-16.17 Million | -0.438x | -68.41% |
| 2021-12-31 | $48.79 Million | $-12.70 Million | -0.260x | +92.08% |
| 2020-12-31 | $2.38 Million | $-7.81 Million | -3.285x | -428.66% |
| 2019-12-31 | $4.59 Million | $-2.85 Million | -0.621x | +79.72% |
| 2018-12-31 | $1.51 Million | $-4.63 Million | -3.065x | -198.08% |
| 2017-12-31 | $5.83 Million | $-5.99 Million | -1.028x | -113.36% |
| 2016-12-31 | $-756.07K | $-5.82 Million | 7.698x | +76.55% |
| 2015-12-31 | $-1.98 Million | $-8.64 Million | 4.360x | -93.97% |
| 2014-12-31 | $-100.33K | $-7.25 Million | 72.265x | +6249.42% |
| 2013-12-31 | $-6.83 Million | $-7.78 Million | 1.138x | -12.16% |
| 2012-12-31 | $-5.74 Million | $-7.43 Million | 1.296x | +353.61% |
| 2011-12-31 | $-21.84 Million | $-6.24 Million | 0.286x | -- |
About Clearpoint Neuro Inc
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which … Read more